CRSP logo

CRISPR Therapeutics AG (CRSP) Non Current Assets

Annual Non Current Assets

$321.49 M
-$68.54 M-17.57%

31 December 2023

CRSP Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$312.24 M
-$17.21 M-5.22%

30 September 2024

CRSP Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CRSP Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.6%-4.3%
3 y3 years+188.7%+3.1%
5 y5 years+1321.2%+452.4%

CRSP Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-17.6%+188.7%-25.8%+3.1%
5 y5 years-17.6%+1321.2%-25.8%+452.4%
alltimeall time-17.6%>+9999.0%-25.8%>+9999.0%

CRISPR Therapeutics AG Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$312.24 M(-5.2%)
June 2024
-
$329.45 M(+3.1%)
Mar 2024
-
$319.39 M(-0.7%)
Dec 2023
$1.91 B(+3.0%)
$321.49 M(-1.5%)
Sept 2023
-
$326.24 M(-3.3%)
June 2023
-
$337.44 M(+0.3%)
Mar 2023
-
$336.40 M(-13.8%)
Dec 2022
$1.85 B(-23.3%)
$390.03 M(-7.3%)
Sept 2022
-
$420.65 M(+18.1%)
June 2022
-
$356.31 M(+3.1%)
Mar 2022
-
$345.56 M(+3.3%)
Dec 2021
$2.42 B(+40.8%)
$334.36 M(+10.4%)
Sept 2021
-
$302.79 M(+8.7%)
June 2021
-
$278.58 M(+121.9%)
Mar 2021
-
$125.55 M(+12.8%)
Dec 2020
$1.72 B
$111.35 M(+18.4%)
Sept 2020
-
$94.08 M(+16.3%)
June 2020
-
$80.91 M(+3.7%)
DateAnnualQuarterly
Mar 2020
-
$78.02 M(-1.5%)
Dec 2019
$987.55 M(+111.7%)
$79.20 M(+40.1%)
Sept 2019
-
$56.52 M(+1.4%)
June 2019
-
$55.77 M(+16.0%)
Mar 2019
-
$48.08 M(+112.5%)
Dec 2018
$466.39 M(+87.8%)
$22.62 M(+1.8%)
Sept 2018
-
$22.21 M(-1.6%)
June 2018
-
$22.58 M(-1.7%)
Mar 2018
-
$22.97 M(+0.1%)
Dec 2017
$248.38 M(-22.4%)
$22.96 M(-3.3%)
Sept 2017
-
$23.73 M(+0.2%)
June 2017
-
$23.69 M(-8.5%)
Mar 2017
-
$25.88 M(+4.5%)
Dec 2016
$320.19 M(+104.1%)
$24.77 M(-47.3%)
Sept 2016
-
$47.00 M(+7.1%)
June 2016
-
$43.90 M(+1599.6%)
Dec 2015
$156.84 M(>+9900.0%)
$2.58 M
Dec 2014
$968.00 K
-

FAQ

  • What is CRISPR Therapeutics AG annual long term assets?
  • What is the all time high annual non current assets for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual non current assets year-on-year change?
  • What is CRISPR Therapeutics AG quarterly long term assets?
  • What is the all time high quarterly non current assets for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly non current assets year-on-year change?

What is CRISPR Therapeutics AG annual long term assets?

The current annual non current assets of CRSP is $321.49 M

What is the all time high annual non current assets for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual long term assets is $390.03 M

What is CRISPR Therapeutics AG annual non current assets year-on-year change?

Over the past year, CRSP annual long term assets has changed by -$68.54 M (-17.57%)

What is CRISPR Therapeutics AG quarterly long term assets?

The current quarterly non current assets of CRSP is $312.24 M

What is the all time high quarterly non current assets for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly long term assets is $420.65 M

What is CRISPR Therapeutics AG quarterly non current assets year-on-year change?

Over the past year, CRSP quarterly long term assets has changed by -$14.01 M (-4.29%)